Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(99)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(120)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(66)
- MDM2(12)
- p53(123)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(145)
- Other Apoptosis(883)
- APC(6)
- PD-1/PD-L1 interaction(90)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(31)
- Cat.No. 产品名称 Information
-
GC41700
(E)-2-(2-Chlorostyryl)-3,5,6-trimethylpyrazine
CSTMP
A stilbene derivative with antioxidant and anticancer activities -
GC41698
(D)2-Rh 110 (trifluoroacetate salt)
D2R, (Asp)2-Rhodamine 110, Rhodamine 110 bis-(L-aspartic acid amide)
A fluorogenic caspase substrate -
GC41645
Jacaric Acid
8(Z),10(E),12(Z)-Octadecatrienoic Acid
A conjugated PUFA -
GC41643
9(Z),11(E),13(E)-Octadecatrienoic Acid
αEleostearic Acid, αESA, LAF 237
A polyunsaturated fatty acid -
GC41642
9(E),11(E),13(E)-Octadecatrienoic Acid
β-Eleostearic Acid, β-ESA
A polyunsaturated fatty acid -
GC41640
Asterriquinol D dimethyl ether
A fungal metabolite
-
GC41623
β-Elemonic Acid
β-岚香酮酸
A triterpene with anticancer activity -
GC41612
2'-O-Methylguanosine
2'-甲氧基鸟苷
A modified nucleoside -
GC41595
Matairesinol
罗汉松脂素
A lignan with diverse biological activities -
GC41584
Penicolinate A
Penicolinate B dimethyl ester
A fungal metabolite with diverse biological activities -
GC41564
MPT0B014
An inhibitor of tubulin polymerization
-
GC41557
(S)-3'-amino Blebbistatin
(-)-3'-amino Blebbistatin, m-amino Blebbistatin, meta-amino Blebbistatin
A more stable form of (–)-blebbistatin -
GC41533
Silybin
水飞蓟宾
Hepatoprotective flavonoid and 5-LO inhibitor -
GC41514
Citreoviridin
黄绿青霉素
A mycotoxin that inhibits the mitochondrial ATPase -
GC41499
α-Phellandrene
水芹烯
A monoterpene with diverse biological activities -
GC41484
(S)-3'-hydroxy Blebbistatin
(-)-3'-hydroxy Blebbistatin, meta-hydroxy-Blebbistatin, m-hydroxy-Blebbistatin
A more stable form of (–)-blebbistatin -
GC41466
Reveromycin A
雷弗霉素A
A spiroketal antibiotic with antiproliferative activity -
GC41452
Luteoloside
木犀草苷; Luteolin 7-glucoside; Luteolin 7-O-β-D-glucoside
A flavanoid with diverse biological activities -
GC41409
Valilactone
缬基内酯,(-)-Valilactone
An esterase inhibitor -
GC41384
K-TMZ
A DNA alkylating agent
-
GC41345
(-)-α-Bisabolol
没药醇; (-)-α-Bisabolol
A sesquiterpene alcohol with diverse biological activities -
GC41342
Terrecyclic Acid
环酸A
A sesquiterpene -
GC41341
Quadrone
夸德尔酮
A sesquiterpene with anticancer activity -
GC41340
Illudin M
隐陡头菌素M
A DNA alkylating agent -
GC41317
CAY10625
An inhibitor of survivin - Smac/DIABLO interaction
-
GC41268
(E)-2-Hexadecenal
trans-2-Hexadecenal
A long-chain fatty aldehyde -
GC41261
Flavokawain B
黄卡瓦胡椒素B,Flavokavain B
Induces cancer cell apoptosis -
GC41183
α-Carotene
α-胡萝卜素
A precursor of vitamin A
-
GC41114
Necrostatin-5
2-[[3,4,5,6,7,8-六氢-3-(4-甲氧基苯基)-4-氧代[1]苯并噻吩并[2,3-D]嘧啶-2-基]硫代]-乙腈
A RIP1 kinase inhibitor -
GC41112
Dihydroxy Melphalan
二羟基美法兰
An inactive degradation product of melphalan -
GC41102
15-deoxy-δ12,14-Prostaglandin D2
15deoxyΔ12,14PGD2
A metabolite of PGD2 and an agonist of DP2 -
GC41080
Albofungin
白真菌素
A xanthone with diverse biological activities -
GC40986
Cinnamamide
肉桂酰胺
An amide of trans-cinnamic acid -
GC40947
2,3-Dimethoxy-5-methyl-p-benzoquinone
2,3-二甲氧基-5-甲基-1,4-苯醌,CoQ0
An intermediate in the synthesis of ubiquinones that has anticancer activity -
GC40932
S-trityl-L-Cysteine
NSC 83265; S-Tritylcysteine; 3-Tritylthio-L-alanine
An inhibitor of Eg5 -
GC40909
Lonicerin
忍冬苦苷
A flavonoid with diverse biological activities -
GC40901
Isogarcinol
Cambogin
A natural benzophenone that has immunosuppressant actions -
GC40878
Chelidonine
白屈菜碱
A tertiary hexahydro-benzophenanthridine alkaloid -
GC40872
Zinquin ethyl ester
乙基2-(2-甲基-8-(4-甲基苯基磺酸基N乙酰胺基)喹啉-6-氧基)乙酸酯
A fluorescent probe for zinc
-
GC40865
LYG-202
A synthetic flavonoid with anticancer and anti-angiogenic activities
-
GC40861
Pinosylvin
赤松素
A stilbene with diverse biological activities -
GC40859
Steffimycin B
司替霉素B
An anthracycline bacterial metabolite -
GC40791
MS-1020
A cell-permeable inhibitor of JAK3
-
GC40785
9(Z),11(E),13(E)-Octadecatrienoic Acid ethyl ester
αESA ethyl ester, Ethyl αeleostearate
A polyunsaturated fatty acid ethyl ester -
GC40760
Nonanoic Acid methyl ester
壬酸甲酯
An esterified form of nonanoic acid -
GC40758
Gly-Phe-β-naphthylamide
(S)-2-(2-氨基乙酰氨基)-N-(萘-2-基)-3-苯基丙酰胺
A cathepsin C substrate -
GC40715
Ascochlorin
壳二孢氯素,Ilicicolin D
An isoprenoid antibiotic and antiviral -
GC40710
9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester
9顺,11反,13反-十八碳三烯酸甲酯
A polyunsaturated fatty acid methyl ester -
GC40698
(-)-Perillyl Alcohol
紫苏醇
A monoterpene alcohol with diverse biological activities -
GC40690
C6 L-threo Ceramide (d18:1/6:0)
L-threo Cer(d18:1/6:0), L-threo Ceramide (d18:1/6:0), N-hexanoyl-L-threo-Sphingosine
A bioactive sphingolipid